Drug Profile
IPI 940
Alternative Names: FAAH inhibitor - Infinity; IPI-940Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Infinity Pharmaceuticals
- Class Non-opioid analgesics
- Mechanism of Action Fatty acid amide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammatory pain; Neuropathic pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Inflammatory-pain(In volunteers) in USA (PO)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Neuropathic-pain(In volunteers) in USA (PO)
- 31 Dec 2012 IPI 940 is available for licensing as of 31 Dec 2012. http://www.infi.com/